Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Kelsey Kimball

Physician Assistant Gainesville, FL Physician Assistant

NPI 1164024253 CMS profile 11124160

1600 Sw Archer Rd, Gainesville, FL 32610

Open in the dashboard

General payments

$41,391

321 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kelsey Kimball of Gainesville, FL is reported in the CMS Open Payments database as having received $41,391 across 321 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $27 1
2023 General $14,083 73
2022 General $20,437 120
2021 General $6,844 127

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelsey Kimball
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kelsey Kimball were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kelsey Kimball Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $6,844 $132 $37–$438 $132
2022 $20,437 $155 $48–$522 $149
2023 $14,083 $167 $52–$557 $160
2024 $27 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Vertos Medical, Inc. $13,559 58 payments
  2. Abbott Laboratories $10,948 64 payments
  3. Boston Scientific Corporation $7,850 104 payments
  4. Saluda Medical Americas, Inc. $5,843 27 payments
  5. Painteq LLC $1,892 12 payments
  6. Medtronic, Inc. $338 10 payments
  7. Nalu Medical, Inc. $321 19 payments
  8. Nevro Corp. $243 17 payments
  9. SPR Therapeutics, Inc $205 2 payments
  10. SI-BONE, Inc. $136 5 payments
  11. Other $56 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Travel and Lodging $13,679 45 payments
  2. Food and Beverage $10,459 236 payments
  3. Consulting Fee $9,725 14 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,919 10 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $1,922 9 payments
  6. Education $1,688 7 payments
Products named General payments · program years 2021–2024
  1. mild Device Kit $13,559 58 payments
  2. PROCLAIM $9,689 51 payments
  3. Evoke SCS $5,843 27 payments
  4. PAINTEQ $1,892 12 payments
  5. Superion Indirect Decompression System $1,642 22 payments
  6. SPECTRA WAVEWRITER $1,625 13 payments
  7. Axium INS DRG IPG $665 2 payments
  8. WAVEWRITER ALPHA $369 14 payments
  9. WaveWriter Alpha Prime 16 $347 17 payments
  10. Nalu Neurostimulation System $321 19 payments
  11. Other $1,920 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

35

Median for Physician Assistant: 241

Drug cost

$31,987

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Daptomycin Generic 18 $31,927
Oxycodone Hcl Generic 17 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record